Autophagy: a new target for nonalcoholic fatty liver disease therapy.
Nonalcoholic fatty liver disease (NAFLD) has gained importance in recent decades due to drastic changes in diet, especially in Western countries. NAFLD occurs as a spectrum from simple hepatic steatosis, steatohepatitis to cirrhosis, and even hepatocellular carcinoma. Although the molecular mechanisms underlying the development of NAFLD have been intensively investigated, many issues remain to be resolved. Autophagy is a cell survival mechanism for disposing of excess or defective organelles, and has become a hot spot for research. Recent studies have revealed that autophagy is linked to the development of NAFLD and regulation of autophagy has therapeutic potential. Autophagy reduces intracellular lipid droplets by enclosing them and fusing with lysosomes for degradation. Furthermore, autophagy is involved in attenuating inflammation and liver injury. However, autophagy is regarded as a double-edged sword, as it may also affect adipogenesis and adipocyte differentiation. Moreover, it is unclear as to whether autophagy protects the body from injury or causes diseases and even death, and the association between autophagy and NAFLD remains controversial. This review is intended to discuss, comment, and outline the progress made in this field and establish the possible molecular mechanism involved.
Department of Gastroenterology and Hepatology, Jinshan Hospital of Fudan University, Shanghai, People's Republic of China.
Yuqing
Y
Mao
Department of Gastroenterology and Hepatology, Jinshan Hospital of Fudan University, Shanghai, People's Republic of China.
Fujun
F
Yu
Department of Gastroenterology and Hepatology, The Central Hospital of Lishui City, Wenzhou Medical University, Zhejiang, People's Republic of China.
Jianbo
J
Wang
Department of Gastroenterology and Hepatology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, People's Republic of China.
Chuanyong
C
Guo
Department of Gastroenterology and Hepatology, Jinshan Hospital of Fudan University, Shanghai, People's Republic of China.
Xiaoming
X
Fan
autophagy; carcinogenesis; fibrosis; nonalcoholic fatty liver disease; steatohepatitis; steatosis